Literature DB >> 9684104

Gene therapy for breast cancer.

H K Boxhorn1, S L Eck.   

Abstract

Gene therapy for breast cancer is still in the very early stages of development. Many of the molecular strategies that have been proposed are also being developed for other cancers. Their application to breast cancer, however, needs to address several issues specific to this disease such as the widespread nature of metastases, the indolent growth of the tumor cells, and the production by the tumor of immunosuppressive agents. Nonetheless, these approaches appear promising, particularly those that employ a combination of strategies. Gene therapies that affect the biology of breast cancer cells or regulate host immune mechanisms have been most successful and may be paired with existing therapies for breast cancer.

Entities:  

Mesh:

Year:  1998        PMID: 9684104     DOI: 10.1016/s0889-8588(05)70014-9

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Breast Cancer Treatment in the Era of Molecular Imaging.

Authors:  Gundula Edelhauser; Martin Funovics
Journal:  Breast Care (Basel)       Date:  2008-12-17       Impact factor: 2.860

Review 2.  Recent advances in imaging endogenous or transferred gene expression utilizing radionuclide technologies in living subjects: applications to breast cancer.

Authors:  F Berger; S S Gambhir
Journal:  Breast Cancer Res       Date:  2000-12-11       Impact factor: 6.466

Review 3.  Gene therapy for carcinoma of the breast: Genetic ablation strategies.

Authors:  D T Curiel
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

Review 4.  Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy.

Authors:  J Gómez-Navarro; W Arafat; J Xiang
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.